BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22842243)

  • 21. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ameloblastic carcinoma developing in preexisting ameloblastoma with a mutation of the p53 gene: a case report.
    Nobusawa A; Sano T; Yokoo S; Oyama T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):e146-50. PubMed ID: 24906942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    Oral Dis; 2001 May; 7(3):171-6. PubMed ID: 11495193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ameloblastic carcinoma: case report and literature review.
    Avon SL; McComb J; Clokie C
    J Can Dent Assoc; 2003 Oct; 69(9):573-6. PubMed ID: 14653932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.
    Otero D; Lourenço SQ; Ruiz-Ávila I; Bravo M; Sousa T; de Faria PA; González-Moles MA
    Oral Dis; 2013 May; 19(4):360-5. PubMed ID: 22970847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of integrin subunits alpha2, alpha3, alpha5, alphav, beta1, beta3 and beta4 in different histological types of ameloblastoma compared with dental germ, dental lamina and adult lining epithelium.
    Modolo F; Martins MT; Loducca SV; de Araújo VC
    Oral Dis; 2004 Sep; 10(5):277-82. PubMed ID: 15315644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral ameloblastic carcinoma: a case report of a rare neoplasm.
    McClatchey KD; Sullivan MJ; Paugh DR
    J Otolaryngol; 1989 Apr; 18(3):109-11. PubMed ID: 2716084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma.
    Pontes HA; Pontes FS; Silva BS; Cury SE; Fonseca FP; Salim RA; Pinto Júnior Ddos S
    Ann Diagn Pathol; 2010 Dec; 14(6):447-52. PubMed ID: 21074695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ameloblastoma and its relationship to ameloblastic fibroma: their histogenesis based on an unusual case and review of the literature.
    Chen SH; Katayanagi T; Osada K; Hamano H; Inoue T; Shimono M; Takano N; Shigematsu T
    Bull Tokyo Dent Coll; 1991 May; 32(2):51-6. PubMed ID: 1819443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic significance of NM23 protein in ameloblastoma and ameloblastic carcinoma: An immunohistochemical study.
    Ladeji A; Olatunji S; Adebiyi K; Olajide M; Kuye O; Aborisade A
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101532. PubMed ID: 37295743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
    Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
    J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts.
    Piattelli A; Fioroni M; Santinelli A; Rubini C
    Oral Oncol; 1998 Sep; 34(5):408-12. PubMed ID: 9861350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Odontogenic tumors: analysis of 706 cases.
    Regezi JA; Kerr DA; Courtney RM
    J Oral Surg; 1978 Oct; 36(10):771-8. PubMed ID: 280645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of Ki-67 antigen in ameloblastoma and its clinical significance].
    Han B; Li L; Wang H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):153-4. PubMed ID: 12838707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of proliferating cell nuclear antigen expression in odontogenic keratocyst and ameloblastoma: an immunohistochemical study.
    Takahashi H; Fujita S; Yamabe S; Moriishi T; Okabe H; Tajima Y; Mizuno A
    Anal Cell Pathol; 1998; 16(4):185-92. PubMed ID: 9762365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor cell proliferation and microsatellite alterations in human ameloblastoma.
    Migaldi M; Sartori G; Rossi G; Cittadini A; Sgambato A
    Oral Oncol; 2008 Jan; 44(1):50-60. PubMed ID: 17307020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.